Mark James Litton, Chief Business Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 9,516 shares at $23.00 ($219K) on 2017-01-05, disclosed to the SEC on 2017-01-09.
Open-market sale of $219k ALDR by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.00 | 2,216 | $51K | 23.3% |
| 2 | $23.02 | 6,800 | $157K | 71.5% |
| 3 | $23.00 | 500 | $12K | 5.3% |
| Total | $23.01 avg | 9,516 | $219K | 100% |
| Filing → |
| ALDR | SELL | 2016-10-19 | $165K | — | Filing → |
| ALDR | SELL | 2016-06-15 | $171K | — | Filing → |
| ALDR | SELL | 2016-06-01 | $751K | — | Filing → |